News

Bloomberg – Proteomics International Alliance and Investment in CPR Pharma

MedTech pioneer Proteomics International (PILL; ASX: PIQ) has entered into a strategic alliance with CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR’s share capital through the issue of 4 million PIQ shares.

Article: Proteomics International Alliance and Investment in CPR Pharma

 

 

Subscribe
  • This field is for validation purposes and should be left unchanged.